Biotech

All Articles

Novartis fires up brand new phase of Voyager contract along with $15M capsid deal

.Novartis is opening a brand new frontier in its partnership with Voyager Therapeutics, paying out $...

Lilly articles more favorable data on its own every week blood insulin prospect

.On the heels of an FDA turndown for its main rivalrous Novo Nordisk, Eli Lilly is actually gaining ...

IN 8bio stops period 2 trial, gives up fifty percent of workforce

.Merely a few months after application the initial client in a stage 2 test for recently detected gl...

Lilly, Haya ink $1B biobuck being overweight pact to explore black genome

.Eli Lilly's search for obesity aim ats has actually led it to the black genome. The Big Pharma has ...

ArsenalBio increases $325M, pivots far from previous lead resource

.Arsenal Biosciences is actually going on up. The cell therapy firm has added $325 thousand in ammo ...

Lilly- backed weight loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis usage medication fails stage 2b, driving Indivior to review $100M possibility

.Aelis Farma's hopes of safeguarding a simple, positive decision on a $one hundred thousand alternat...

ProKidney stops period 3 trial certainly not needed for cell therapy authorization

.ProKidney has stopped among a set of stage 3 trials for its own cell treatment for kidney illness a...

Vaxcyte climbs on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what experts called "stunning" stage 1/2 information for its own 31-valent pneumoc...

Recursion's human brain disease trial reveals scant evidence of efficiency

.Recursion has actually stumbled via a very early test of its own tech-enabled technique to medicine...